Merck licenses innovative anti-cancer therapy LM-299 from LaNova Medicines

Pallavi Madhiraju- November 14, 2024

In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as MSD outside the U.S. and Canada, has ... Read More

Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India

Pallavi Madhiraju- August 24, 2024

Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More

Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

pallavi123- December 29, 2021

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More

Gland Pharma gets FDA tentative approval for Sugammadex Injection

pallavi123- October 8, 2021

Gland Pharma has secured tentative approval from the US Food and Drug Administration (FDA) for Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 ... Read More

Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial

pallavi123- June 29, 2021

Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More

Divi’s Laboratories to manufacture API of MSD’s Covid drug Molnupiravir

pallavi123- May 27, 2021

Divi's Laboratories Limited has been selected by pharma giant MSD (known as Merck in the US and Canada) as an authorized manufacturer for the active ... Read More

Cipla partners with MSD to manufacture and distribute Molnupiravir drug to treat Covid-19

pallavi123- April 28, 2021

Cipla has entered into a non-exclusive licensing agreement with MSD (called Merck in the US and Canada) for the manufacturing and distribution of Molnupiravir (EIDD-2801/MK-4482), ... Read More

Pharma giants bag Lynparza EMA approval for metastatic breast cancer

pharmanewsdaily- May 19, 2019

Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency's (EMA) approval for their poly ADP-ribose polymerase ... Read More